Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Youth Employment Program

Alberta Research Chemicals Inc.

$30,000.00

Development of Novel EGFR Inhibitors as Cancer Therapeutics

FY 2025-26 · 2025-07-01

Summary
Firm would like to design and develop novel EGFR (epidermal growth factor receptor) inhibitor cancer therapeutic that improve selectivity to allow irreversible inhibition to overcome resistance mutations. EGFR plays a central role in cell proliferation and survival. Aberrant EGFR signaling is a driver mutation in many tumors, making it an ideal and validated target for cancer therapy. Despite many pharmaceutical companies actively advancing EGFR inhibitors, drug resistance and severe side effects remain unsolved challenges that need to be addressed.
Program
Industrial Research Assistance Program – Youth Employment Program
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
835357500
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2026-03-31
Agreement Number
1032219
Agreement Start Date
2025-07-01
Agreement Title
Development of Novel EGFR Inhibitors as Cancer Therapeutics
Agreement Title (French)
Développement de nouveaux inhibiteurs de l’EGFR pour le traitement du cancer
Agreement Type
Contribution
Agreement Value
$30,000.00
Amendment Number
0
Coverage
IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation. | Les projets du Programme Emploi-jeunesse du PARI stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Firm would like to design and develop novel EGFR (epidermal growth factor receptor) inhibitor cancer therapeutic that improve selectivity to allow irreversible inhibition to overcome resistance mutations. EGFR plays a central role in cell proliferation and survival. Aberrant EGFR signaling is a driver mutation in many tumors, making it an ideal and validated target for cancer therapy. Despite many pharmaceutical companies actively advancing EGFR inhibitors, drug resistance and severe side effects remain unsolved challenges that need to be addressed.
Description (French)
L’entreprise souhaite concevoir et développer de nouveaux inhibiteurs de l’EGFR (récepteur du facteur de croissance épidermique) pour le traitement du cancer qui améliorent la sélectivité pour permettre une inhibition irréversible afin de surmonter les mutations de résistance. L’EGFR joue un rôle central dans la prolifération et la survie des cellules. La signalisation aberrante de l’EGFR est une mutation déterminante dans de nombreuses tumeurs, ce qui en fait une cible idéale et validée pour le traitement du cancer. Bien que de nombreuses sociétés pharmaceutiques développent activement des inhibiteurs de l’EGFR, la résistance aux médicaments et les effets secondaires graves restent des défis non résolus qui doivent être abordés.
Expected Results
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Expected Results (French)
Le Programme Emploi-jeunesse du PARI contribue à accroître le bassin de personnes hautement qualifiées, fait la promotion des études supérieures, démontre le leadership fédéral grâce aux investissements effectués dans l’acquisition des compétences requises pour répondre aux besoins de l’économie du savoir et facilite la transition des jeunes hautement qualifiés vers un marché du travail en évolution rapide.
Federal Riding
Edmonton Mill Woods
Federal Riding (French)
Edmonton Mill Woods
Federal Riding Number
48017
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Youth Employment Program
Program Name (French)
Programme d’aide à la recherche industrielle – Programme emploi jeunesse
Program Purpose
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Program Purpose (French)
Le Programme Emploi-jeunesse du PARI contribue à accroître le bassin de personnes hautement qualifiées, fait la promotion des études supérieures, démontre le leadership fédéral grâce aux investissements effectués dans l’acquisition des compétences requises pour répondre aux besoins de l’économie du savoir et facilite la transition des jeunes hautement qualifiés vers un marché du travail en évolution rapide.
Recipient Business Number
835357500
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Alberta Research Chemicals Inc.
Recipient Postal Code
T6E 5P8
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q2-1032219
Alberta Research Chemicals Inc. - $30,000 Contributio… | Canada Spends